메뉴 건너뛰기




Volumn 18, Issue 18, 2002, Pages 1333-1337

Scaling HIV vaccine attitudes among Gay men in Sydney, Australia

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

EID: 0036936448     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202320935401     Document Type: Article
Times cited : (14)

References (16)
  • 3
    • 0030819266 scopus 로고    scopus 로고
    • Risk behavior for HIV infection in participants in preventive HIV vaccine trials: A cautionary note
    • Chesney MA, Chambers DB, and Kahn JO: Risk behavior for HIV infection in participants in preventive HIV vaccine trials: A cautionary note. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:266-271.
    • (1997) J Acquir Immune Defic Syndr Hum Retrovirol , vol.16 , pp. 266-271
    • Chesney, M.A.1    Chambers, D.B.2    Kahn, J.O.3
  • 4
    • 0028072401 scopus 로고
    • Participation of homosexual/bisexual men in preventive HIV vaccine trials: Baseline attitudes and concerns and predicted behaviors during trials
    • Douglas JM, Judson FN, Parks JP, Buchbinder S, and McKiman D: Participation of homosexual/bisexual men in preventive HIV vaccine trials: Baseline attitudes and concerns and predicted behaviors during trials. AIDS Res Hum Retroviruses 1994;10(Suppl. 2):S257-S260.
    • (1994) AIDS Res Hum Retroviruses , vol.10 , Issue.SUPPL. 2
    • Douglas, J.M.1    Judson, F.N.2    Parks, J.P.3    Buchbinder, S.4    McKiman, D.5
  • 5
    • 0033081284 scopus 로고    scopus 로고
    • Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials
    • Hays RB and Kegeles SM: Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:164-171.
    • (1999) J Acquir Immune Defic Syndr Hum Retrovirol , vol.20 , pp. 164-171
    • Hays, R.B.1    Kegeles, S.M.2
  • 6
    • 7144253781 scopus 로고    scopus 로고
    • Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States
    • Koblin BA, Heagerty P, Sheon A, et al.: Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS 1998;12:785-793.
    • (1998) AIDS , vol.12 , pp. 785-793
    • Koblin, B.A.1    Heagerty, P.2    Sheon, A.3
  • 7
    • 0030751565 scopus 로고    scopus 로고
    • Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE
    • Koblin BA, Avrett S, Taylor PE, and Stevens CE: Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:165-171.
    • (1997) J Acquir Immune Defic Syndr Hum Retrovirol , vol.15 , pp. 165-171
    • Koblin, B.A.1    Avrett, S.2    Taylor, P.E.3    Stevens, C.E.4
  • 9
    • 0034671883 scopus 로고    scopus 로고
    • Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil
    • Périssé ARS, Schechter M, Moreira RI, et al.: Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. JAIDS 2000;25:459-463.
    • (2000) JAIDS , vol.25 , pp. 459-463
    • Périssé, A.R.S.1    Schechter, M.2    Moreira, R.I.3
  • 10
    • 0035146849 scopus 로고    scopus 로고
    • Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three U.S. communities
    • Strauss RP, Sengupta S, Kegeles S, et al.: Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three U.S. communities. JAIDS 2001;26:63-71.
    • (2001) JAIDS , vol.26 , pp. 63-71
    • Strauss, R.P.1    Sengupta, S.2    Kegeles, S.3
  • 11
    • 0034927271 scopus 로고    scopus 로고
    • Trial-related discrimination in HIV vaccine clinical trials
    • Allen M, Israel H, and Rybczyk K: Trial-related discrimination in HIV vaccine clinical trials. AIDS Res Hum Retroviruses 2001;17:667-674.
    • (2001) AIDS Res Hum Retroviruses , vol.17 , pp. 667-674
    • Allen, M.1    Israel, H.2    Rybczyk, K.3
  • 13
    • 51249161901 scopus 로고
    • Tolerance of ambiguity: A review of the concept, its measurement and applications
    • Furnham A and Ribchester T: Tolerance of ambiguity: A review of the concept, its measurement and applications. Curr Psychol Dev Learning Personality Social 1995;14:179-199.
    • (1995) Curr Psychol Dev Learning Personality Social , vol.14 , pp. 179-199
    • Furnham, A.1    Ribchester, T.2
  • 14
    • 84980139560 scopus 로고
    • Ambiguity seeking in multi-attribute decisions: Effects of optimism and message framing
    • Bier VM: Ambiguity seeking in multi-attribute decisions: Effects of optimism and message framing. J Behav Decis Making 1994;7:169-182.
    • (1994) J Behav Decis Making , vol.7 , pp. 169-182
    • Bier, V.M.1
  • 15
    • 0030690436 scopus 로고    scopus 로고
    • Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men
    • Bartholow BN, MacQueen KM, Douglas JM, et al.: Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:108-115.
    • (1997) J Acquir Immune Defic Syndr Hum Retrovirol , vol.16 , pp. 108-115
    • Bartholow, B.N.1    MacQueen, K.M.2    Douglas, J.M.3
  • 16
    • 0033080822 scopus 로고    scopus 로고
    • Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials
    • Scheer S, Douglas, JM, Vittinghoff E. et al.: Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:172-178.
    • (1999) J Acquir Immune Defic Syndr Hum Retrovirol , vol.20 , pp. 172-178
    • Scheer, S.1    Douglas, J.M.2    Vittinghoff, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.